DilenyTech

We are excited to start a new chapter of AI innovation with Astute Imaging.

Astute Imaging Acquires Deep Technology AI Startup DilenyTech The Acquisition Will Enable Astute Imaging to Expedite the Development of an AI Driven image-guided Therapy Platform Kirkland, WA – March 15, 2022 - Astute Imaging LLC, a provider of imaging-guided therapy and procedure planning services, announced the acquisition of Dileny Technologies (DilenyTec...

More towards innovation and validation for DilenyTech's AI technologies with Medical partners.

In a recent clinical study, our ultrasound AI-enabled elastography software US-Elasto© was used to compare the elasticity of different breast masses using conventional ultrasound images. The study was performed by notable researchers at Cairo University School of Medicine and published in the Egyptian Journal of Radiology and Nuclear Medicine.

US-Elasto AI technology was granted a patented from the United States Patent and Trademark Office in 2021.
For research details: https://link.springer.com/article/10.1186/s43055-022-00703-5

Comparative study between conventional ultrasound strain elastography and an AI-enabled elastography software in differentiating breast masses - Egyptian Journal of Radiology and Nuclear Medicine Background Conventional ultrasound elastography is a relatively novel noninvasive imaging study that assesses tissue stiffness and helps in the characterization of breast lesions. However, strain elastography is not available in some ultrasound machines especially those before 2003 and is susceptibl...

Another fruit of the long-term and wonderful collaboration between Women And Fetal Imaging مركز وافي للأشعة and DilenyTech in breast imaging!
We are glad to announce that another research is accepted at the European Congress of Radiology ECR 2022. The work addresses a state-of-the-art topic in breast imaging entitled "Two view low dose digital mammography combined with a single view wide-angle digital breast tomosynthesis versus full-field digital mammography; impact on the glandular dose and clinic performance"
Thank you WAFI team led by Prof. Hanan Gewefel and Dr. Iman Ewais for this opportunity to work with you.

We were blessed in 2021 with great achievements at DilenyTech, and more good news to come in 2022!

We are pleased to start 2022 with the new achievements of our R&D team at Dilenytech in the field of AI and breast imaging!

DilenyTech has been part of two research abstracts that have been just accepted in the ECR 2022 meeting in collaboration with top medical researchers and organizations in the field of breast imaging.

DilenyTech has been selected as one of the most promising and growing AI healthcare startups.

Stay tuned for more news!

Don't miss NVIDIA 's interesting session
"Accelerating Med Tech Deployment in Emerging Markets"
with Dr. Ahmed Ehab A. Mahmoud, Founder, and chief innovation officer of DilenyTech
Tuesday, Nov 9 | 4:00 PM EET
Register now: https://www.nvidia.com/gtc/